Cannabidiol shortage — PE supply status & alternatives

Cannabidiol

—

🇦🇺 AUST R 328860

In supply · Australia

Procaps Neviot

In supply · 🇦🇺 Australia · short in🌐 PE

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Controlled substance
Active ingredient (INN)	Cannabidiol
Brand names	Procaps Neviot
Therapeutic category	Auto-created by DIGEMID — Discontinuidad de Medicamentos (Peru) scraper

Registrations on file	1

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

17 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Farmabios SPADivision Of Therapeutics & Medical Consequences/Nida/Nih/HhsBenuvia Operations LLCThc Pharm GMBHVeranova LPYunnan Hansu Biotechnology CO LTD+11 more

Manufacturing countries: Italy, United States, Taiwan, China, India, Canada, Spain · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders1 registration

Product	Strength	Form	Market	MA holder	Status
EPIDYOLEX cannabidiol	100 mg	—	🇦🇺 AU	—	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.